Nevro Corp.
NYSE: NVRO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin R. Thornal
- Employees
- 1,099
- Headquarters
- Redwood City, United States
- IPO year
- 2014
- Market cap
- $224.1M
- Website
- https://www.nevro.com
Loading NVRO…
Loading profile data…Frequently asked questions about NVRO
What does Nevro Corp. (NVRO) do?
Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically support...
Where does NVRO trade?
Nevro Corp. (NVRO) trades on the New York Stock Exchange.
What sector is NVRO in?
Nevro Corp. (NVRO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Nevro Corp.?
Kevin R. Thornal is the chief executive officer of Nevro Corp. (NVRO).
Where is Nevro Corp. headquartered?
Nevro Corp. is headquartered in United States.
Does NVRO pay a dividend?
Nevro Corp. (NVRO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVRO go public?
Nevro Corp. (NVRO) completed its initial public offering in 2014.